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Pin1 actively regulates diverse biological/pathological processes, but little is known about the regu-
latory mechanisms of its cellular localization. In this study, we report that the endogenous Pin1 is
distributed in both nucleus and cytoplasm. We found that point mutations of several basic amino
acids in the PPIase domain of Pin1 signiﬁcantly compromise its nuclear localization. Such inhibition
is independent of Pin1 enzymatic activity, and is mainly due to the defects in the nuclear import. A
novel sequence harboring these residues was identiﬁed as a putative nuclear localization signal
(NLS) of Pin1. Importin a5 of the nuclear import machinery was found to interact with Pin1.
Structured summary:
MINT-6803320: PIN1 (uniprotkb:Q13255) and importin alpha 5 (uniprotkb:P52294) physically interact
(MI:0218) by anti tag coimmunoprecipitation (MI:0007)
MINT-6803333: importin alpha 3 (uniprotkb:O00505) and PIN1 (uniprotkb:Q13255) physically interact
(MI:0218) by anti tag coimmunoprecipitation (MI:0007)
MINT-6803357: PIN1 (uniprotkb:Q13255) physically interacts (MI:0218) with importin alpha 5 (uni-
protkb:P52294) by anti bait coimmunoprecipitation (MI:0006)
MINT-6803345: St3 (uniprotkb:P40763) and importin alpha 5 (uniprotkb:P52294) physically interact
(MI:0218) by anti tag coimmunoprecipitation (MI:0007)
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Peptidyl-prolyl isomerase (PPIase) Pin1 was ﬁrstly isolated as a
NIMA kinase interacting protein [1]. Later, Pin1 was found to spe-
ciﬁcally recognize the proline bond preceded by a phosphorylated
serine or threonine residue (phosphoSer/Thr-Pro motif) and cata-
lyze the prolyl-peptidyl cis–trans isomerization [2]. In recent years,
a growing number of proteins has been reported as Pin1’s sub-
strates, including tumor suppressor p53 [3,4], proto-oncogene
c-Myc [5], cell-cycle proteins cdc25 [6], cyclin D1 [7], and many
others proteins that are generally not related to each others. In
addition, there are also growing evidences suggesting that Pin1
plays important roles in the pathogenesis of Alzheimer’s disease
[8], apoptosis of neurons [9] and mammary epithelial cell transfor-
mation [10]. All these ﬁndings suggest that Pin1 plays a very
diverse role in the regulation of different biological/pathological
processes.
With the deepening understanding of Pin1’s biological func-
tions [11], the protein appears to play an active role in both nuclearchemical Societies. Published by E
Cao).and cytoplasmic compartments of the cell. Pin1 has been reported
to regulate activities of multiple transcriptional factors such as c-
fos [12], c-Jun [7], NF-jB [13] and Stat3 [14]. Moreover, Pin1 di-
rectly modulates RNA polymerase II (RNAP II) [15,16], and plays
an important role in mitotic chromosome condensation by forma-
tion of a complex with chromatin and topoisomerase aII [17]. All
these suggest a nuclear function of Pin1. However, the underlying
mechanism regulating Pin1 nuclear localization remains unclear.
In this study, we report that wild-type Pin1 is distributed in
both nucleus and cytoplasm of mammalian cells, and its nuclear
localization is severely compromised upon point-mutations at sev-
eral key residues (K63, R68, and R69). For the ﬁrst time, a novel nu-
clear localization signal (NLS) of Pin1, which overlaps with its
catalytic domain, has been identiﬁed. In addition, Pin1 has also
been found to interact with human importin a5.
2. Materials and methods
2.1. Construction of expression plasmids
Full-length Pin1 was generated by PCR from human cDNA
library (Clontech, Mountain View, CA, USA), and the respective
PCR product was sequenced and cloned into pXJ40-Myc andlsevier B.V. All rights reserved.
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47–85 of Pin1 protein, was cloned into pXJ40-GST expression
plasmid using PCR. All the point mutants for Pin1 were generated
by site-directed mutagenesis (Promega, Madison, WI, USA)
according to the manufacturer’s instruction using the wild-type
Pin1 as template. Mammalian expression plasmids of various
importins in pXJ40-Myc vector were generated as described
previously [19].
2.2. Cell fractionation
Cells were harvested and resuspended in nuclear extraction
buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl and
0.5% NP-40) and the suspension was incubated on ice for 10 min,
followed by appropriate homogenization with Teﬂon pestles. The
nuclear fraction was collected by centrifugation of the homogenate
at 4000 rpm for 10 min at 4 C, and lysed in RIPA buffer. The super-
natant of the homogenate was centrifuged at 14 000 rpm for
20 min and collected as the cytoplasmic fraction.
2.3. Immunoprecipitation and Western blotting
Cell lysates containing 1 mg of total proteins were subjected to
immunoprecipitation/blotting as described previously [20].
2.4. Immunoﬂuorescence
Immunoﬂuorescence was performed as described previously
[21]. Brieﬂy, cells grown on coverslips were transfected with vari-
ous expression plasmids in 6-well plates. Cells were ﬁxed with 4%
paraformaldehyde and permeabilized with 0.2% Triton X-100. After
blocking with FCS, the cells were incubated with primary antibod-
ies, followed by Cy2 or Cy3-conjugated secondary antibodies
(Amersham Biosciences, Piscataway, NJ, USA). Samples were exam-
ined using confocal microscopy (BioRad Radiance 2000).Fig. 1. Nuclear localization of Pin1 point mutant R68,69A is impaired. (A) HepG2 cells
extraction assay. Endogenous Pin1 was detected with polyclonal anti-Pin1 antibody. Th
controls for cell-fractionation and loading efﬁciency. (B) HeLa cells were transfected with
harvested and subjected to fractionation, and the nuclear and cytoplasmic portions were
controls. (C) Pin1 KO MEFs were transfected with Myc-Pin1 or R68,69A mutant, and eithe
to immunoﬂuorescence staining using anti-Myc antibody, followed by Cy3-conjugated s3. Results
3.1. Nuclear localization of Pin1 is impaired upon point mutations at
Arg68 and 69
To characterize the subcellular distribution of Pin1, HepG2 cells
were subjected to cellular fractionation. Endogenous Pin1 proteins
were found in both nuclear and cytoplasmic fractions in the nor-
mal growing cells, and the distribution pattern was not changed
by treatment of cells with interleukin-6 (IL-6) (Fig. 1A). This result
agrees with our previous observation in HeLa cells [14], and is also
consistent with its diverse roles in regulating various substrates
from different cellular compartments. To further investigate the
mechanism regulating Pin1 nuclear localization, wild-type Pin1
and its three point mutants, Y23A, W34A, and R68,69A were trans-
fected into HeLa cells, and cellular fractionation was performed.
Overexpressed wild-type Pin1, Y23A and W34A mutants, were
found in both the nuclear and cytoplasmic fractions (Fig. 1B), with
the two mutants showing relatively enriched cytoplasmic staining.
Interestingly, nuclear localization of the double point mutant,
R68,69A, was severely compromised. To further conﬁrm this obser-
vation, Pin1 knockout MEF cells [22] were transfected with wild-
type Pin1 or R68,69A mutant. Consistent with the nuclear extrac-
tion results, immunostaining of R68,69A mutant in the nucleus
was signiﬁcantly impaired compared to its wild-type counterpart,
which was distributed in both nucleus and cytoplasm (Fig. 1C).
Stimulation of cells with cytokine oncostatin M (OSM) does not af-
fect the localization of either wild-type Pin1 or R68,69A mutant.
3.2. Nuclear export of Pin1 is CRM-1-independent
Point mutations at R68 and R69 residues of Pin1 signiﬁcantly
impaired its nuclear localization (Fig. 1B and C). Next we studied
whether the double point mutation also leads to nuclear export
abnormality. HeLa cells were treated with nuclear export inhibitorwere left untreated or stimulated with IL-6 (40 ng/ml), and subjected to nuclear
e blot was stripped and reprobed with antibodies against PARP and a-tubulin as
Myc-tagged wild-type Pin1 and point-mutants Y23A, W34A or R68,69A. Cells were
analyzed by Western blotting with anti-Myc antibody. PARP and a-tubulin served as
r left untreated or stimulated with OSM (10 ng/ml) for 20 min. Cells were subjected
econdary antibody.
Fig. 2. Nuclear export of Pin1 is CRM-1 independent. HeLa cells were transfected with Myc-Pin1 or R68,69A mutant, and either left untreated or incubated with 20 nM of
nuclear export inhibitor LMB for 4 h in (A), or 20 nM overnight (lanes 2 and 5) or 100 nM for 4 h (lanes 3 and 6) in (B) before harvesting. The nuclear and cytoplasmic fractions
were subjected to Western analysis with anti-Myc antibody, with staining of endogenous PARP and a-tubulin as controls. (C) Western blotting of endogenous MEK1 in HeLa
cells treated with 20 nM LMB overnight was shown as the positive control of LMB efﬁciency.
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wild-type Pin1 or R68,69A mutant was studied. Apparently, inhibi-
tion of CRM-1-dependent nuclear export did not lead to any signif-
icant increase of R68,69A in the nuclear fraction (Fig. 2A). We next
increased the concentration (100 nM) or duration (overnight) of
LMB treatment, and the results further conﬁrmed this observation
(Fig. 2B). As a positive control for the LMB efﬁciency, nuclear accu-
mulation of endogenous MEK1 was increased in HeLa cells treated
with 20 nM LMB overnight (Fig. 2C), which is in consistent with a
previous report [23]. Since the nuclear accumulation of both Pin1
and mutant proteins was not affected by LMB treatment, this resultFig. 3. Pin1 nuclear localization is independent of its PPIase activity. (A) HeLa cells wer
incubated with Pin1-speciﬁc PPIase inhibitor Juglone (1 lM) for 6 h. Cells were subjected
transfected with wild-type Pin1 or point mutants R68,69A, K63A, or C113A. Cells wer
schematic diagram of the structural domains of Pin1, including the position of mutations a
domain.suggests that the nuclear export of Pin1 protein is most likely inde-
pendent of CRM-1.
3.3. Nuclear localization of Pin1 is independent of its PPIase enzymatic
activity
Double point mutation at amino acid Arg68 and 69 of Pin1 abol-
ishes its PPIase activity [2], raising the possibility that this activity
is required for Pin1 nuclear localization. However, inhibition of
Pin1 PPIase activity by a Pin1-speciﬁc PPIase inhibitor, juglone
[24] did not cause any signiﬁcant change in the nuclear localizatione transfected with Myc-Pin1 or Myc-R68,69A mutant, and either left untreated or
to nuclear extraction andWestern analysis as described in Fig. 2. (B) HeLa cells were
e subjected to nuclear extraction and Western analysis as described above. (C) A
nd the sequence of core NLS. Numbers indicate amino acids. WW: substrate binding
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ﬁrm this, two other point mutants of Pin1, K63A and C113A [25],
which are also PPIase-activity-deﬁcient, were generated and exam-
ined. C113A exhibited normal nuclear localization pattern as the
wild-type Pin1 in transfected HeLa cells (Fig. 3B), suggesting that
the loss of Pin1 PPIase enzymatic activity is not the cause of the im-
paired nuclear localization.
Interestingly, the other mutant, K63A, in which the amino acid
residue is also basic and in close proximity to the R68,69 residues,
showed impaired nuclear localization similar to that shown in
R68,69A (Fig. 3B). This observation led us to speculate that the se-
quence harboring the amino acids K63, R68, and R69, may actually
represents a nuclear localization signal (NLS) of the Pin1 protein
(Fig. 3C).Fig. 4. Identiﬁcation of the NLS of Pin1 protein. (A and B) HeLa cells were transfected wi
were subjected to nuclear extraction and Western analysis using anti-GST, anti-PARP, or
and subjected to immunoﬂuorescence staining using anti-GST antibody, followed by Cy
Fig. 5. Interaction of importin a5 with Pin1. (A) HeLa cells were co-transfected with HA-P
total proteins were subjected to immunoprecipitation with anti-Myc antibodies, and
precipitated Pin1 is indicated by an arrow, and heavy (H) and light (L) chains of IgG are in
antibody (upper left panel), and expression of HA-Pin1 in the total cell lysates was show
a5 in OSM-treated cells was shown as a positive control, and co-precipitated Stat3
immunoprecipitation with anti-Pin1 antibodies, and followed by Western blotting analys
total cell lysates was shown in the bottom panel.3.4. Identiﬁcation of the NLS of Pin1 Protein
To examine this hypothesis, a short amino acid sequence (aa
47–aa 85) ﬂanking the putative core NLS harboring K63 and R68/
R69 residues, were adopted as a putative NLS and cloned into
pXJ40-GST, a mammalian GST expression vector. While a majority
of GST proteins was enriched in the cytoplasmic portion, signiﬁ-
cant amount of NLS-GST fusion proteins appeared in the nuclear
fraction (Fig. 4A). These results provide a direct evidence that the
sequence containing K63, R68,69 serves as a core NLS which may
account for the nuclear localization of Pin1 proteins. To further
support this, either K63 or R68/69 was selectively mutated, and
the mutated NLS-GST fusion proteins disappeared from the nu-
cleus (Fig. 4B), which is consistent with the behavior of Pin1 pointth pXJ40-GST, NLS-GST plasmids or point mutants R68,69A or K63A as labeled. Cells
anti-a-tubulin antibody. (C) HeLa cells were transfected with NLS-GST or mutants,
2-conjugated secondary antibody.
in1 and various Myc-importin as or empty vector (v). Cell lysates containing 1 mg of
the precipitates were analyzed by Western blotting using anti-HA antibody. Co-
dicated (middle left panel). The same blot was stripped and reprobed with anti-Myc
n in the bottom left panel. Co-immunoprecipitation of Flag-Stat3 and Myc-importin
is indicated by an arrow (right panels). (B) HeLa cell lysates were subjected to
is using anti-importin a5 and anti-Pin1 antibodies. Endogenous importin a5 level in
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ther performed to conﬁrm the localization of NLS-GST fusion and
its mutants by visualization of cells (Fig. 4C).
3.5. Interaction between Pin1 and importin a5
Import of NLS-containing protein into nucleus is usually medi-
ated by the importin a/b transport system. Importin as are respon-
sible for speciﬁc recognition and binding to the target NLS. So far,
six human importin as have been reported, among which ﬁve
members are ubiquitously expressed [26,27]. Upon the identiﬁca-
tion of NLS in Pin1 protein, we next investigated possible importin
as involved in the regulation of Pin1’s nuclear import. Importin a5
and importin a3, albeit weaker, were found to interact with Pin1
(Fig. 5A). As a positive control, OSM-stimulated Stat3 interacted
with importin a5, as previously reported [19]. Importin a5 is a
common binding partner to both Pin1 and Stat3. However, Pin1
also interacts with importin a3, whereas Stat3 interacts with
importin a7, suggesting their binding speciﬁcity to importins. Both
Pin1 and Stat3 did not interact with importin b directly (data not
shown). To further conﬁrm that Pin1 and importin a5 proteins
interact at their endogenous protein level, we performed an IP/
WB test in untransfected HeLa cell lysates, and endogenous impor-
tin a5 is co-precipitated together with Pin1 proteins (Fig. 5B).
4. Discussion
Generally, small molecules in cells may undergo passive diffu-
sion through nuclear pore complexes (NPCs), and larger proteins
are transported into nucleus via active cargo-carrier transport sys-
tems [26,27]. However, there are also some small proteins, such as
histone, whose nuclear import was mainly mediated by active
transport machinery [28,29]. In the case of Pin1, which is about
18 kDa, mutations at a single amino acid (K63) or two residues
(R68 and R69) do not affect the molecular mass of Pin1 signiﬁ-
cantly. Meanwhile, according to the structural analysis data of
Pin1 protein [30], amino acids R68 and R69 are located in a loop
region of Pin1. With their side chains sticking out from the mole-
cule, these two residues make relatively less contacts with other
amino acids in the protein. Therefore, substitution of R68,69 in
our experiments is unlikely to change the overall protein folding
signiﬁcantly. Nevertheless, such single/double point mutations
compromise Pin1 nuclear localization severely (Fig. 1B and C,
Fig. 3B), which suggests that nuclear transport mechanisms other
than simple diffusion must play a dominant role in the regulation
of its cellular distribution.
Importin a/b complex-mediated nuclear transport mainly rec-
ognize the classical NLS, namely the SV40 large-T antigen type,
or the nucleoplasmin type, which consists of two stretches of basic
residues separated by a spacer [26,27]. The putative NLS in Pin1, as
shown in Fig. 3C, is mainly comprised of 3 basic amino acids with a
spacer of 5 residues in between, which is similar to but does not
exactly resemble the classical NLS. Our results suggest that Pin1
nuclear transport might be predominantly mediated by importin
transport system, by showing the interaction of Pin1 with importin
a5 (Fig. 5).
It has been noticed that, despite the inhibition of nuclear local-
ization upon point mutations at K63 or R68,69 residues, certain
amounts of mutant proteins were still observed in the nucleus
(Fig. 3B, top left panel). As discussed above, with small molecular
mass of 18 kDa for Pin1, free diffusion of the proteins may contrib-
ute partly to the nuclear presence of the mutants. Interestingly, it
was recently reported that Pin1 colocalizes with phosphatase
inhibitor-2, and the nuclear/cytoplasmic distribution of both pro-
teins is affected by cell density [31]. In addition, since Pin1 playsimportant roles in the regulation of the cell cycle, the subcellular
distribution of Pin1 may be also affected by the progression of
the cell cycle. All these suggest the possible existence of other
mechanisms regulating the cellular distribution of Pin1 in addition
to the NLS identiﬁed above. On the other hand, cellular fraction-
ation data in HepG2 (Fig. 1A), HeLa [14], and COS-1 cells (data
not shown) revealed that nuclear Pin1 proteins may consist of a
relatively small fraction of the total endogenous Pin1 proteins in
cell. It will be interesting to know, on top of the NLS identiﬁed here,
whether the nuclear portion of Pin1 is differentially post-transla-
tionally modiﬁed compared to its cytoplasmic counterpart, which
makes it speciﬁcally residing inside the nucleus. Alternatively,
Pin1 proteins may shuttle between the nucleus and cytoplasm.
It is noteworthy that Polo-like kinase 1 speciﬁcally phosphory-
lates Ser65 residue of Pin1 protein, which inhibits ubiquitination of
Pin1 and therefore stabilizes the protein [32]. The Ser65 residue
falls inside the putative NLS region, therefore it will also be inter-
esting to know whether phosphorylation of Ser65 affects the nu-
clear import of Pin1, or whether cellular distribution of Pin1
inﬂuences stability of the protein itself.
To date, increasing number of nuclear- or cytoplasmic-localized
proteins have been reported as Pin1 substrates, many of which are
involved in fairly diverse or distinct cellular events. A better under-
standing of the mechanism controlling the nuclear transport of
Pin1, especially in different biological/ pathological conditions, will
deﬁnitely provide more clues towards the regulatory roles of Pin1
protein in vivo.
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